|
|
Christian Jones shares the latest in nanotechnology advancements including recent clinical data, formulation applications, and API optimization to NanoImprove formulations through superior bioavailability, drug loading, route of administration, pill burden, and more. |
|
|
|
Explore how bioavailability of poorly soluble APIs can be improved and patient compliance enhanced by reducing the size or number of tablets that a patient must take to achieve the required dose. |
|
|
|
Understand how the latest in nanotechnology can help improve formulations, and learn about new data on nanotechnology formulations for multiple dose forms and routes of delivery, including oral, long-acting injectables, inhalation, and ophthalmic. |
|
|
|
Cutting-edge nanotechnology is emerging, with strong clinical evidence, as an alternative to amorphous solid dispersion (ASD), able to address bioavailability challenges and deliver higher drug loads in more patient-friendly formats with fewer and smaller pills and easier regimens. |
|
|
|
Learn about the challenges to effective delivery of drugs to the eye, intricacies of ophthalmic drug delivery, and advantages of nanoparticles as an enabling technology for ocular drug-delivery systems. |
|
|
|
|
| Connect with us at the CPHI or AAPS events to discuss how you can NanoImprove your molecule — set up a meeting at info@nanoform.com. |
|
|
